Total submissions: 5
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Illumina Laboratory Services, |
RCV001138068 | SCV001298093 | uncertain significance | Alport syndrome | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
| Gene |
RCV001593288 | SCV001825596 | uncertain significance | not provided | 2020-02-27 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Occurs in the triple helical domain at the X position in the canonical Gly-X-Y repeat; although this variant may have an effect on normal protein folding and function, missense substitution at the X position is not a common mechanism of disease; Has not been previously published as pathogenic or benign to our knowledge |
| Fulgent Genetics, |
RCV002491414 | SCV002785664 | uncertain significance | Autosomal recessive Alport syndrome; Benign familial hematuria | 2021-12-10 | criteria provided, single submitter | clinical testing | |
| Labcorp Genetics |
RCV001593288 | SCV003448049 | likely benign | not provided | 2024-01-25 | criteria provided, single submitter | clinical testing | |
| Natera, |
RCV001138068 | SCV002084151 | uncertain significance | Alport syndrome | 2020-09-24 | no assertion criteria provided | clinical testing |